COMBINATION CHEMOTHERAPY OF METASTATIC BONE AND SOFT-TISSUE SARCOMAS

被引:0
|
作者
SUTHERLAND, C
MORGAN, LR
CARTER, D
KREMENTZ, E
机构
[1] TULANE UNIV,SCH MED,DEPT SURG,NEW ORLEANS,LA 70112
[2] LOUISIANA STATE UNIV,SCH MED,DEPT PHARMACOL,NEW ORLEANS,LA 70112
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:137 / 137
页数:1
相关论文
共 50 条
  • [1] COMBINATION CHEMOTHERAPY (CYVADIC) IN METASTATIC SOFT-TISSUE SARCOMAS
    KARAKOUSIS, CP
    RAO, U
    PARKS, HC
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (01): : 33 - 36
  • [2] CHEMOTHERAPY FOR METASTATIC SOFT-TISSUE SARCOMAS
    LECESNE, A
    PRESSE MEDICALE, 1995, 24 (26): : 1214 - 1220
  • [3] CHEMOTHERAPY OF ADVANCED SARCOMAS OF BONE AND SOFT-TISSUE
    ANTMAN, KH
    SEMINARS IN ONCOLOGY, 1992, 19 (06) : 13 - 22
  • [4] Chemotherapy in pediatric bone and soft-tissue sarcomas
    Browning, Meghen B.
    Mortland, Leslie J.
    Malogolowkin, Marcio H.
    CURRENT ORTHOPAEDIC PRACTICE, 2013, 24 (03): : 239 - 243
  • [5] CHEMOTHERAPY FOR BONE AND SOFT-TISSUE SARCOMAS OF THE EXTREMITIES
    YASKO, AW
    LANE, JM
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1991, 73A (08): : 1263 - 1271
  • [6] CHEMOTHERAPY OF REFRACTORY BONE AND SOFT-TISSUE SARCOMAS WITH IFOSFAMIDE ALONE AND IN COMBINATION WITH CISPLATIN
    SCHUTTE, J
    NIEDERLE, N
    SEEBER, S
    SCHMIDT, CG
    BLUT, 1984, 49 (03): : 264 - 265
  • [7] FAILURE OF COMBINATION CHEMOTHERAPY (CYVADIC) IN METASTATIC SOFT-TISSUE SARCOMAS - IMPLICATIONS FOR ADJUVANT STUDIES
    GIULIANO, AE
    LARKIN, KL
    EILBER, FR
    MORTON, DL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 359 - 359
  • [8] PREOPERATIVE AND POSTOPERATIVE CHEMOTHERAPY IN BONE AND SOFT-TISSUE SARCOMAS
    HOFFKEN, K
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1987, 372 : 311 - 314
  • [9] CHEMOTHERAPY IN COMPLEX TREATMENT OF BONE AND SOFT-TISSUE SARCOMAS
    MATEJOVSKY, Z
    ONCOLOGY, 1980, 37 : 97 - 103
  • [10] Chemotherapy for Soft-Tissue Sarcomas
    Ravi, Vinod
    Patel, Shreyaskumar
    ONCOLOGY-NEW YORK, 2015, 29 (01): : 43 - 50